| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/09/2003 | CN1429267A Neural progenitor cell populations |
| 07/09/2003 | CN1429235A Full-length infectious CDNA clones of tick borne flavivirus |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428419A Method for preparing fertilized ovum chromosome |
| 07/09/2003 | CN1428418A Culture method of external tissue and its fatiscent carrier |
| 07/09/2003 | CN1428353A Antihuman hemoglobin monoclonal antibody |
| 07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 07/09/2003 | CN1113962C Stress resistant plant in which cell death suppressing gene is introduced and method for producing same |
| 07/09/2003 | CN1113961C Gene expression regulatory NDA, expression cassette and expression carrier |
| 07/09/2003 | CN1113960C Genetic sequences of encoding flavonoid pathway enzymes and use therefor |
| 07/08/2003 | US6590141 Nucleic acid molecules from plants encoding enzymes which participate in starch synthesis |
| 07/08/2003 | US6590139 Method for producing cloned cows |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/08/2003 | US6590075 Secreted protein HODAZ50 |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589786 Stem cells; cancer; electroporation; cell size; dielectric membrane; Use in the selection, purification, and/or purging of desired (stem) or undesired (cancer) cells from cell suspensions |
| 07/08/2003 | US6589785 Disrupting cells and/or tissue in solid state in presence of solid denaturing substance |
| 07/08/2003 | US6589782 VEGF (Vascular Endothelial Growth Factor); adenovirus vector; Use in treating cardiovascular disorders, enhancing the neovascularization of diseased blood vessels and enhancing drug delivery via improved vascular permeability |
| 07/08/2003 | US6589769 Method for cloning and expression of TspRI restriction endonuclease and TspRI methylase in E. coli |
| 07/08/2003 | US6589767 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 07/08/2003 | US6589765 Yield of paclitaxel from Taxus cell cultures is increased by optimizing incubation temperature with cell growth stage, by increasing cell inoculum size, and increased level of maltose in the medium; use in improving industrial production |
| 07/08/2003 | US6589759 Thrombopoietin as thrombopoiesis stimulating factor and S-nitrosoglutathione as nitiric oxide donor; use for treating and preventing blood disorders |
| 07/08/2003 | US6589747 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 07/08/2003 | US6589728 Methods for isolation and activation of, and control of differentiation from, stem and progenitor cells |
| 07/08/2003 | US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening |
| 07/08/2003 | US6589531 Recombinant yellow fever virus and method of use thereof |
| 07/08/2003 | US6589530 Hepatitis B surface antigen vaccine |
| 07/08/2003 | US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment |
| 07/08/2003 | US6589528 Contacting monocytes with monoclonal antibody that binds to fusion regulatory Protein-1 exposed on surface of monocytes |
| 07/08/2003 | US6589526 Enrichment of dendritic cells from blood |
| 07/08/2003 | US6589525 Method and device for preparing a dental implant by immersion in a culture of mesenchymal cells |
| 07/08/2003 | CA2263883C Kuz, a novel family of metalloproteases |
| 07/08/2003 | CA2133646C Stem cell proliferation factor |
| 07/08/2003 | CA2068593C Method for reducing the immunogenicity of antibody variable domains |
| 07/08/2003 | CA2035384C Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries") |
| 07/03/2003 | WO2003054552A2 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 07/03/2003 | WO2003054540A1 Dna encoding a human receptor (hp15a) and uses thereof |
| 07/03/2003 | WO2003054221A1 Imp dehydrogenase and the use of the same for identifying fungicidally active compounds |
| 07/03/2003 | WO2003054220A1 Reporter gene assay method |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054213A2 NON-HUMAN PRIMATE Fc RECEPTORS AND METHODS OF USE |
| 07/03/2003 | WO2003054212A2 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 07/03/2003 | WO2003054210A2 Regulated nucleic acid expression system |
| 07/03/2003 | WO2003054203A1 Isolation tool for viable c-kit expressing cells |
| 07/03/2003 | WO2003054199A2 Phytases and method for producing these phytases |
| 07/03/2003 | WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | WO2003054193A2 Raf/ras binding compounds |
| 07/03/2003 | WO2003054188A2 Seminal vesicle tissue-specific promoters and uses thereof |
| 07/03/2003 | WO2003054185A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 07/03/2003 | WO2003054184A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 07/03/2003 | WO2003054180A1 Modified mek1 and mek2, crystal of a peptide: ligand: cofactor complex containing such modified mek1 or mek2, and methods of use thereof |
| 07/03/2003 | WO2003054177A2 New glycosyl hydrolases |
| 07/03/2003 | WO2003054174A1 Method for large scale production of virus antigen |
| 07/03/2003 | WO2003054172A2 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 07/03/2003 | WO2003054171A1 Method for differentiating islet precursor cells into beta cells |
| 07/03/2003 | WO2003054170A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 07/03/2003 | WO2003054169A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability |
| 07/03/2003 | WO2003054163A2 Methods for producing hyaluronan in a recombinant host cell |
| 07/03/2003 | WO2003054160A2 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 07/03/2003 | WO2003054159A2 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | WO2003054158A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
| 07/03/2003 | WO2003054153A2 Apyrase polypeptides and nucleic acids encoding same |
| 07/03/2003 | WO2003054142A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | WO2003054138A1 Cell culture instrument and method of separating and subculturing cells |
| 07/03/2003 | WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
| 07/03/2003 | WO2003053921A2 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | WO2003053857A1 Forming and modifying dielctrically-engineered microparticles |
| 07/03/2003 | WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells |
| 07/03/2003 | WO2003053343A2 Novel compounds that enhance dimerization of the subunits of hiv-1 reverse transcriptase having mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors |
| 07/03/2003 | WO2003053332A2 Composition and method for treating viral infection |
| 07/03/2003 | WO2003053224A2 Novel compositions and methods for cancer |
| 07/03/2003 | WO2003053216A2 Biodegradable, porous structures useful for growing living tissue, and methods of manufacture |
| 07/03/2003 | WO2003053139A1 Disruption of the phosphodiesterase 10 gene |
| 07/03/2003 | WO2003053138A1 Transgenic expression of glycogen synthase kinase 3 in muscle |
| 07/03/2003 | WO2003034038A3 Flow control metering system and method for controlling filtration of liquid-based specimens |
| 07/03/2003 | WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 07/03/2003 | WO2003018788A3 Improved nitroreductase enzymes |
| 07/03/2003 | WO2003007786A3 Porous delivery scaffold and method |
| 07/03/2003 | WO2002101009A3 Structural and cytoskeleton-associated proteins |
| 07/03/2003 | WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/03/2003 | WO2002090495A8 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 07/03/2003 | WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor |
| 07/03/2003 | WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 07/03/2003 | WO2002057468A3 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 07/03/2003 | WO2002057305A3 A gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages |
| 07/03/2003 | WO2002050285A3 Histone deacetylase-related gene and protein |
| 07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
| 07/03/2003 | WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins |
| 07/03/2003 | WO2002036761A3 Compositions and methods for the diagnosis of cancer |
| 07/03/2003 | WO2002024733A3 Human polynucleotides and polypeptides encoded thereby |
| 07/03/2003 | WO2002012447B1 Isolation and use of solid tumor stem cells |
| 07/03/2003 | WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/03/2003 | WO2001083750A9 Dendritic cell co-stimulator molecules |